Legal and regulatory experts expect litigation to arise if the FDA seeks to enforce its pharma DTC ad crackdown, though how it might play out is nuanced.
The pharmaceutical giant that helped the world fight Covid-19 has announced plans to list its shares in New York… on the same day that the boss of rival GlaxoSmithKline steps aside. Is Big Pharma ...
Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback